Carfilzomib

Overview

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC 50 of 5 nM in ANBL-6 and RPMI 8226 cells.

Application

Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Proteasome | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-10455
• CAS No.: 868540-17-4
• Molecular Formula: C40H57N5O7
• Molecular Weight: 719.91
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years * The compound is unstable in solutions, freshly prepared is recommended.
• Solubility: 2.5 mg/mL (3.47 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source